News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
691,530 Results
Type
Article (40652)
Company Profile (295)
Press Release (650583)
Section
Business (205342)
Career Advice (2001)
Deals (35536)
Drug Delivery (89)
Drug Development (81340)
Employer Resources (168)
FDA (16238)
Job Trends (14889)
News (347074)
Policy (32906)
Tag
Academia (2576)
Alliances (49787)
Alzheimer's disease (1243)
Approvals (16164)
Artificial intelligence (130)
Bankruptcy (354)
Best Places to Work (11583)
Biotechnology (212)
Breast cancer (119)
Cancer (1084)
Cardiovascular disease (97)
Career advice (1669)
Cell therapy (236)
Clinical research (64578)
Collaboration (387)
Compensation (197)
COVID-19 (2574)
C-suite (96)
Data (1119)
Diabetes (154)
Diagnostics (6172)
Earnings (85006)
Employer resources (146)
Events (110175)
Executive appointments (307)
FDA (16770)
Funding (349)
Gene therapy (180)
GLP-1 (584)
Government (4421)
Healthcare (18750)
Infectious disease (2658)
Inflammatory bowel disease (110)
Interviews (309)
IPO (16361)
Job creations (3664)
Job search strategy (1427)
Layoffs (418)
Legal (7914)
Lung cancer (174)
Manufacturing (182)
Medical device (13244)
Medtech (13249)
Mergers & acquisitions (19245)
Metabolic disorders (402)
Neuroscience (1520)
NextGen Class of 2024 (6550)
Non-profit (4493)
Northern California (1478)
Obesity (230)
Opinion (187)
Patents (102)
People (56647)
Phase I (20079)
Phase II (28425)
Phase III (21226)
Pipeline (455)
Postmarket research (2566)
Preclinical (8560)
Radiopharmaceuticals (235)
Rare diseases (221)
Real estate (5978)
Regulatory (21857)
Research institute (2347)
Resumes & cover letters (350)
Southern California (1304)
Startups (3615)
United States (13464)
Vaccines (567)
Weight loss (167)
Date
Today (130)
Last 7 days (827)
Last 30 days (3764)
Last 365 days (35833)
2024 (32819)
2023 (40332)
2022 (51487)
2021 (56040)
2020 (54408)
2019 (46852)
2018 (35304)
2017 (32485)
2016 (31855)
2015 (37923)
2014 (31692)
2013 (26709)
2012 (28881)
2011 (29574)
2010 (27569)
Location
Africa (727)
Arizona (192)
Asia (37804)
Australia (6144)
California (3325)
Canada (1283)
China (248)
Colorado (143)
Connecticut (151)
Europe (81095)
Florida (455)
Georgia (116)
Illinois (338)
Indiana (197)
Kansas (96)
Maryland (592)
Massachusetts (2604)
Michigan (157)
Minnesota (278)
New Jersey (956)
New York (953)
North Carolina (702)
Northern California (1478)
Ohio (140)
Pennsylvania (840)
South America (1107)
Southern California (1304)
Texas (458)
Utah (90)
Washington State (359)
691,530 Results for "abcellera biologics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AbCellera Reports Q3 2024 Business Results
November 4, 2024
·
11 min read
Press Releases
AbCellera to Present at Upcoming Investor Conferences in November 2024
October 22, 2024
·
1 min read
Press Releases
AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024
November 7, 2024
·
4 min read
Business
AbCellera Reports Q1 2024 Business Results
AbCellera (Nasdaq: ABCL) today announced financial results for the first quarter of 2024.
May 7, 2024
·
12 min read
Business
AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024
AbCellera (Nasdaq: ABCL) will announce its second quarter 2024 financial results on Tuesday, August 6, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.
June 25, 2024
·
1 min read
Business
AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions
AbCellera (Nasdaq: ABCL) and Biogen Inc. (Nasdaq: BIIB) have entered into a strategic collaboration to discover antibodies for a novel target that enables the delivery of biotherapeutics to the brain for indications in neuroscience.
March 11, 2024
·
3 min read
Press Releases
AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024
September 27, 2024
·
1 min read
AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024, at 12:20 p.m. Pacific Time (3:20 p.m. Eastern Time).
May 28, 2024
·
1 min read
Business
AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies
AbCellera, Viking Global Investors, and ArrowMark Partners announced that they have entered into a collaboration to advance new antibody drug programs with an aim to launch multiple asset-based companies.
May 1, 2024
·
4 min read
AbCellera to Present at Upcoming Investor Conferences in March 2024
AbCellera announced that executives from the Company will present at the following investor conferences.
February 22, 2024
·
1 min read
1 of 69,153
Next
